- Lobbying
- Lobbying by Martek Biosciences Corporation
Lobbying Relationship
Bills mentioned
S.510: FDA Food Safety Modernization Act
Sponsor: Richard J. Durbin (D-Ill.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Joshua Greene | SALACongEngel93-95;LACongNadler96-99 |
Stephanie Peters | LCSenJudic89;LCOPM90;AttAdvOPM90-95;MCHRComJud95-9 |
William Bright | RDirSenJudC97-9LASJudAS95-7SASJudTLS93-5RSPL92-3 |
Darryl Nirenberg | PSSenAgCom83-87;CDSDSenFRCom87-91;CSSenHelms81-95 |
Jean McCue | n/a |
Paul Rubin | n/a |
Stuart Pape | n/a |
Neil Potts | n/a |
Laurence Harris | n/a |
Elizabeth Ryan | n/a |
William McGinley | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Management & Budget (OMB)
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Management & Budget (OMB)
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of Management & Budget (OMB)
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
Federal Trade Commission (FTC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
Federal Trade Commission (FTC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
Federal Trade Commission (FTC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
Federal Trade Commission (FTC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Advertising
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Advertising
Health Issues
Registration
Issue(s) they said they’d lobby about: FDA regulatory issues associated with authoritative statement nutrient
content claims..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate